Search - tctmd.com

Displaying 1 - 20 of 131

Sort: Relevancy | Date

News Conference News TCT 2025

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

Yael L. Maxwell

November 04, 2025

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

Todd Neale

November 03, 2025

Presentation TCT 2025

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

Presenter: Claudio Laudani

October 28, 2025

Presentation TCT 2025

TCT 1014: Cost-effectiveness of clopidogrel versus aspirin for chronic maintenance therapy after percutaneous coronary intervention: results from the HOST-EXAM Extended study

Presenter: Jeehoon Kang

October 28, 2025

Presentation TCT 2025

TCT 1008: Aspirin vs. Clopidogrel as Monotherapy for Secondary Prevention in Stable Coronary Artery Disease: An Updated Meta Analysis

Presenter: Timothy Charles Shuey

October 27, 2025

Presentation TCT 2025

TCT 997: Long-Term Clopidogrel vs Aspirin Monotherapy in coronary artery disease patients with High Ischemic Risk: HOST-EXAM Extended Study Post Hoc Analysis

Presenter: Jin-Eun Song

October 27, 2025

Presentation TCT 2025

TCT 54: Outcomes with Ticagrelor Versus Clopidogrel for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Propensity-Matched Analysis

Presenter: Ahmed Younes

October 26, 2025

Presentation TCT 2025

TCT 226: Aspirin Versus Clopidogrel Following Transcatheter Aortic Valve Replacement: A TVT Registry Propensity Matched Analysis

Presenter: Yuri Pride

October 25, 2025

Presentation TCT 2025

Clopidogrel Monotherapy Following 1-Month DAPT vs. Aspirin Monotherapy Following 12-Month DAPT After PCI in ACS Patients: Final 5-Year Results of the STOPDAPT-2 ACS Trial

Presenter: Hirotoshi Watanabe

October 25, 2025

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

Presentation TCT 2024

TCT 7: Impact of Use of Proton Pump Inhibitor in Patients Taking Clopidogrel: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mobeen Haider

October 27, 2024

Presentation TCT 2024

TCT 229: Rebound Phenomenon of Platelet Reactivity After Cessation of Long-term Clopidogrel Therapy

Presenter: Jung-Kyu Han

October 27, 2024

Presentation TCT 2024

TCT 991: Ticagrelor Versus Clopidogrel in Cancer Patients With Acute Myocardial Infarction

Presenter: Andres Cordova Sanchez

October 27, 2024

Presentation TCT 2024

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

Presenter: Jeehoon Kang

October 27, 2024

Presentation TCT 2023

TCT 11: Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction

Presenter: Sang Hyun Kim

October 25, 2023

Presentation TCT 2023

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

Presenter: Cole Clifford

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

Presentation TCT 2023

Aspirin or Clopidogrel for Chronic Management?

Presenter: Fausto Feres

October 24, 2023

Presentation TCT 2023

Clopidogrel Monotherapy Following 1-month DAPT versus Aspirin Monotherapy Following 12-month DAPT in Patients Receiving PCI; Final 5-year Result of STOPDAPT-2

Presenter: Hirotoshi Watanabe

October 23, 2023

News Conference News TCT 2022

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

Todd Neale

September 21, 2022

Advertisement

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

TCT 1014: Cost-effectiveness of clopidogrel versus aspirin for chronic maintenance therapy after percutaneous coronary intervention: results from the HOST-EXAM Extended study

TCT 1008: Aspirin vs. Clopidogrel as Monotherapy for Secondary Prevention in Stable Coronary Artery Disease: An Updated Meta Analysis

TCT 997: Long-Term Clopidogrel vs Aspirin Monotherapy in coronary artery disease patients with High Ischemic Risk: HOST-EXAM Extended Study Post Hoc Analysis

TCT 54: Outcomes with Ticagrelor Versus Clopidogrel for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Propensity-Matched Analysis

TCT 226: Aspirin Versus Clopidogrel Following Transcatheter Aortic Valve Replacement: A TVT Registry Propensity Matched Analysis

Clopidogrel Monotherapy Following 1-Month DAPT vs. Aspirin Monotherapy Following 12-Month DAPT After PCI in ACS Patients: Final 5-Year Results of the STOPDAPT-2 ACS Trial

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

TCT 7: Impact of Use of Proton Pump Inhibitor in Patients Taking Clopidogrel: A Meta-Analysis of Randomized Controlled Trials

TCT 229: Rebound Phenomenon of Platelet Reactivity After Cessation of Long-term Clopidogrel Therapy

TCT 991: Ticagrelor Versus Clopidogrel in Cancer Patients With Acute Myocardial Infarction

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

TCT 11: Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Aspirin or Clopidogrel for Chronic Management?

Clopidogrel Monotherapy Following 1-month DAPT versus Aspirin Monotherapy Following 12-month DAPT in Patients Receiving PCI; Final 5-year Result of STOPDAPT-2

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content